BearDownAZ's Recent Posts
Title ▲ Rating Company Posted on
BioPharm America 2017, Sep. 26-27, Boston, MA 5 Resverlogix Corp. Sep 16, 2017 11:36AM
BioPub Bioasis Webcast 2 BIOASIS TECHNOLOGIES INC Sep 30, 2019 10:34PM
BioRxiv article on Mtfp-siRNA 1 BIOASIS TECHNOLOGIES INC May 18, 2020 10:23AM
Biotech Showcase 2 Zenith Epigenetics Dec 17, 2018 12:24PM
Biotech Showcase January 8-10, 2018 4 Resverlogix Corp. Dec 15, 2017 11:54AM
Biotech Showcase January 8-10, 2018 2 Zenith Epigenetics Dec 15, 2017 11:55AM
Biotech Showcase January 8-10, 2018 1 BIOASIS TECHNOLOGIES INC Dec 15, 2017 11:56AM
Biotech Showcase Presentation is up 2 Resverlogix Corp. Jan 07, 2019 08:08PM
Biotech Showcase, Jan 13-15 3 Resverlogix Corp. Dec 13, 2019 09:07AM
Blinded Sub Group Data; post by Aureus on IV 6 Resverlogix Corp. Oct 04, 2018 12:12PM
Bloom Burton & Co Healthcare Conference 6 Resverlogix Corp. Apr 19, 2018 12:44PM
Bloom Burton Slides 3 Resverlogix Corp. May 02, 2018 03:03PM
BRD4 inhibition and FXR activation, individually beneficial in cholestasis, are antagonistic in combination 5 Resverlogix Corp. Jan 06, 2021 11:25AM
BRD4 inhibition and PARP Inhibition 1 Zenith Epigenetics Mar 14, 2018 11:22AM
BRD4 Interacts with GATA4 to Govern Mitochondrial Homeostasis in Adult Cardiomyocytes 5 Resverlogix Corp. Apr 17, 2020 05:15PM
BRD4 regulates metastatic potential of castration-resistant prostate cancer through AHNAK 7 Zenith Epigenetics May 20, 2019 05:09PM
BRD4/Nrf2/ARE signaling is implicated in the pathogenesis of diabetic nephropathy 4 Resverlogix Corp. Jul 24, 2019 02:59PM
Breaking Down Barriers: BiOasis Technologies Promises Breakthrough Brain Drug Delivery 2 BIOASIS TECHNOLOGIES INC Jun 19, 2018 02:08PM
Breakthrough Junior Challenge 2016 video about the blood brain barrier 1 BIOASIS TECHNOLOGIES INC Nov 12, 2016 04:03PM
Bromodomain and Extraterminal Proteins as Novel Epigenetic Targets for Renal Diseases 11/8/19 7 Resverlogix Corp. Nov 23, 2019 10:33AM